DUS 2078, Organic — Inorganic compound fertilizer — Specification, First edition

Product Image

Distribution date: 10 October 2018 | Final date for Comment: 09 December 2018

This Draft Uganda standard specifies the requirements, sampling and test methods of organic–inorganic compound fertilizers.

Products Covered: Organic-inorganic compound fertilizer

Regulation Type: Regular notification

Notice of Amendment the Prescription Drug List (PDL): Hydroquinone The Notice of Consultation and subsequent Notice of Intent to Amend for the proposal to add hydroquinone to the Prescription Drug List (PDL) when sold in a concentration greater than 2% in topical products was notified in G/TBT/N/CAN/516 (dated 7 February 2017) and in G/TBT/N/CAN/516/Add.1 (dated 15 February 2018). On 1 October 2018, Health Canada published on its website the Notice amendment indicating that Health Canada will add certain hydroquinone products to the Prescription Drug List (PDL).  Only the Human part of the PDL has been revised. Health Canada has conducted a scientific review of hydroquinone against the criteria in section C.01.040.3 of the Food and Drug Regulations.  The new listing remains unchanged from what was proposed in the 1 February 2017, Notice of Consultation. This revision will be in effect as of 30 June 2019. The full text of the adopted measure can be downloaded from the Internet addresses indicated below: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-prescription-drug-list-2018-08-22.html (English) https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/avis-liste-drogues-ordonnance-2018-08-22.html (French) or requested from: Canada's SPS & TBT Notification Authority and Enquiry Point Global Affairs Canada Technical Barriers and Regulations Division 111 Sussex Drive, Ottawa, ON K1A 0G2 Canada Telephone: (343)203-4273 Fax: (613)943-0346  E-mail: [email protected]

Product Image

Distribution date: 10 October 2018

Products Covered: Prescription status of medicinal ingredients for human use (ICS: 11.120; HS 3004.90)

Regulation Type: Addendum to Regular Notification

Notice of Amendment the Prescription Drug List (PDL): Hydroquinone The Notice of Consultation and subsequent Notice of Intent to Amend for the proposal to add hydroquinone to the Prescription Drug List (PDL) when sold in a concentration greater than 2% in topical products was notified in G/TBT/N/CAN/516 (dated 7 February 2017) and in G/TBT/N/CAN/516/Add.1 (dated 15 February 2018). On 1 October 2018, Health Canada published on its website the Notice amendment indicating that Health Canada will add certain hydroquinone products to the Prescription Drug List (PDL).  Only the Human part of the PDL has been revised. Health Canada has conducted a scientific review of hydroquinone against the criteria in section C.01.040.3 of the Food and Drug Regulations.  The new listing remains unchanged from what was proposed in the 1 February 2017, Notice of Consultation. This revision will be in effect as of 30 June 2019. The full text of the adopted measure can be downloaded from the Internet addresses indicated below: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-prescription-drug-list-2018-08-22.html (English) https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/avis-liste-drogues-ordonnance-2018-08-22.html (French) or requested from: Canada's SPS & TBT Notification Authority and Enquiry Point Global Affairs Canada Technical Barriers and Regulations Division 111 Sussex Drive, Ottawa, ON K1A 0G2 Canada Telephone: (343)203-4273 Fax: (613)943-0346  E-mail: [email protected]

Product Image

Distribution date: 10 October 2018

Products Covered: Prescription status of medicinal ingredients for human use (ICS: 11.120; HS 3004.90)

Regulation Type: Addendum to Regular Notification

DUS 2081, Compound microbial fertilizer — Specification, First edition

Product Image

Distribution date: 10 October 2018 | Final date for Comment: 09 December 2018

This Draft Uganda Standard specifies requirements and methods of sampling and test for compound microbial fertilizers.

Products Covered: Compound microbial fertilizer

Regulation Type: Regular notification

DUS 2081, Compound microbial fertilizer — Specification, First edition

Product Image

Distribution date: 10 October 2018 | Final date for Comment: 09 December 2018

This Draft Uganda Standard specifies requirements and methods of sampling and test for compound microbial fertilizers.

Products Covered: Compound microbial fertilizer

Regulation Type: Regular notification

DUS 2038, Blended fertilizer — Specification, First edition

Product Image

Distribution date: 10 October 2018 | Final date for Comment: 09 December 2018

This Draft Uganda Standard specifies the requirements for blended fertilizers (or physical mixtures of fertilizers) intended for use as fertilizers.

Products Covered: Blended fertilizers

Regulation Type: Regular notification

DUS 2038, Blended fertilizer — Specification, First edition

Product Image

Distribution date: 10 October 2018 | Final date for Comment: 09 December 2018

This Draft Uganda Standard specifies the requirements for blended fertilizers (or physical mixtures of fertilizers) intended for use as fertilizers.

Products Covered: Blended fertilizers

Regulation Type: Regular notification

Prohibición de los principios activos carbofuran, carbosulfan, diazinon, aldicarb y dicofol y sus productos formulados (Ban on the active ingredients carbofuran, carbosulfan, diazinon, aldicarb, dicofol and their formulated products) (2 pages, in Spanish)

Product Image

Distribution date: 10 October 2018

The manufacture, importation and fractionation of the active ingredients carbofuran, carbosulfan, diazinon, aldicarb, dicofol and their formulated products shall be prohibited beginning 365 days from the entry into force of this measure. Ten % granular formulations of carbofuran are excluded from the ban. Enterprises that have any of these products, registered in the National Plant Therapeutics Register, must declare their inventories and indicate the number of containers, capacity, batch and expiry date.

Products Covered: Pesticide active ingredients Insecticides, rodenticides, fungicides, herbicides, anti-sprouting products and plant-growth regulators, disinfectants and similar products, put up in forms or packings for retail sale or as preparations or articles (for example, sulphur-treated bands, wicks and candles, and fly-papers) (HS 3808).

Regulation Type: Regular notification

Prohibición de los principios activos carbofuran, carbosulfan, diazinon, aldicarb y dicofol y sus productos formulados (Ban on the active ingredients carbofuran, carbosulfan, diazinon, aldicarb, dicofol and their formulated products) (2 pages, in Spanish)

Product Image

Distribution date: 10 October 2018

The manufacture, importation and fractionation of the active ingredients carbofuran, carbosulfan, diazinon, aldicarb, dicofol and their formulated products shall be prohibited beginning 365 days from the entry into force of this measure. Ten % granular formulations of carbofuran are excluded from the ban. Enterprises that have any of these products, registered in the National Plant Therapeutics Register, must declare their inventories and indicate the number of containers, capacity, batch and expiry date.

Products Covered: Pesticide active ingredients Insecticides, rodenticides, fungicides, herbicides, anti-sprouting products and plant-growth regulators, disinfectants and similar products, put up in forms or packings for retail sale or as preparations or articles (for example, sulphur-treated bands, wicks and candles, and fly-papers) (HS 3808).

Regulation Type: Regular notification

Partial amendment to the Minimum Requirements for Biological Products

Product Image

Distribution date: 08 October 2018 | Final date for Comment: 07 November 2018

The Minimum Requirements for Biological Products shall be partially amended to revise the standard for the "Human Serum Albumin"and "pH-4 Treated Acidic Normal Human Immunoglobulin (Subcutaneous injection)".

Products Covered: Pharmaceutical products (HS: 30)

Regulation Type: Regular notification

Submit your email ID to receive notifications about upcoming courses and events